BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

186 related articles for article (PubMed ID: 21761348)

  • 1. Quantitative immunohistochemical analysis and prognostic significance of TRPS-1, a new GATA transcription factor family member, in breast cancer.
    Chen JQ; Litton J; Xiao L; Zhang HZ; Warneke CL; Wu Y; Shen X; Wu S; Sahin A; Katz R; Bondy M; Hortobagyi G; Berinstein NL; Murray JL; Radvanyi L
    Horm Cancer; 2010 Feb; 1(1):21-33. PubMed ID: 21761348
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prognostic value of the trichorhinophalangeal syndrome-1 (TRPS-1), a GATA family transcription factor, in early-stage breast cancer.
    Chen JQ; Bao Y; Lee J; Murray JL; Litton JK; Xiao L; Zhou R; Wu Y; Shen XY; Zhang H; Sahin AA; Katz RL; Bondy ML; Berinstein NL; Hortobagyi GN; Radvanyi LG
    Ann Oncol; 2013 Oct; 24(10):2534-2542. PubMed ID: 23729783
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Expression and relevance of TRPS-1: a new GATA transcription factor in breast cancer.
    Chen JQ; Bao Y; Litton J; Xiao L; Zhang HZ; Warneke CL; Wu Y; Shen X; Wu S; Katz RL; Sahin A; Bondy M; Murray JL; Radvanyi L
    Horm Cancer; 2011 Apr; 2(2):132-43. PubMed ID: 21761336
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Association of TRPS1 gene with different EMT markers in ERα-positive and ERα-negative breast cancer.
    Su P; Hu J; Zhang H; Jia M; Li W; Jing X; Zhou G
    Diagn Pathol; 2014 Jun; 9():119. PubMed ID: 24934762
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Utility of TRPS-1 immunohistochemistry in diagnosis of metastatic breast carcinoma in cytology specimens.
    Abdelwahed M; Yurtsever N; Savant D; Karam P; Gimenez C; Das K; Sheikh-Fayyaz S; Khutti S
    J Am Soc Cytopathol; 2022; 11(6):345-351. PubMed ID: 36055933
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Clinicopathological implications of Tiam1 overexpression in invasive ductal carcinoma of the breast.
    Li Z; Liu Q; Piao J; Hua F; Wang J; Jin G; Lin Z; Zhang Y
    BMC Cancer; 2016 Aug; 16(1):681. PubMed ID: 27562113
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prognostic significance of androgen receptor expression in invasive breast cancer: transcriptomic and protein expression analysis.
    Aleskandarany MA; Abduljabbar R; Ashankyty I; Elmouna A; Jerjees D; Ali S; Buluwela L; Diez-Rodriguez M; Caldas C; Green AR; Ellis IO; Rakha EA
    Breast Cancer Res Treat; 2016 Sep; 159(2):215-27. PubMed ID: 27514395
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Biological and prognostic associations of miR-205 and let-7b in breast cancer revealed by in situ hybridization analysis of micro-RNA expression in arrays of archival tumour tissue.
    Quesne JL; Jones J; Warren J; Dawson SJ; Ali HR; Bardwell H; Blows F; Pharoah P; Caldas C
    J Pathol; 2012 Jul; 227(3):306-14. PubMed ID: 22294324
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Keratin 17 is overexpressed and predicts poor survival in estrogen receptor-negative/human epidermal growth factor receptor-2-negative breast cancer.
    Merkin RD; Vanner EA; Romeiser JL; Shroyer ALW; Escobar-Hoyos LF; Li J; Powers RS; Burke S; Shroyer KR
    Hum Pathol; 2017 Apr; 62():23-32. PubMed ID: 27816721
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Forkhead box A1 expression in breast cancer is associated with luminal subtype and good prognosis.
    Thorat MA; Marchio C; Morimiya A; Savage K; Nakshatri H; Reis-Filho JS; Badve S
    J Clin Pathol; 2008 Mar; 61(3):327-32. PubMed ID: 18037662
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Roles of trichorhinophalangeal syndrome-1 gene in normal breast development and breast cancer].
    Bao Y; Zhong ZX; Cui G; Guo L; Wang ZF
    Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 2013 Feb; 35(1):121-4. PubMed ID: 23469802
    [TBL] [Abstract][Full Text] [Related]  

  • 12. High levels of γ-glutamyl hydrolase (GGH) are associated with poor prognosis and unfavorable clinical outcomes in invasive breast cancer.
    Shubbar E; Helou K; Kovács A; Nemes S; Hajizadeh S; Enerbäck C; Einbeigi Z
    BMC Cancer; 2013 Feb; 13():47. PubMed ID: 23374458
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Elevated cyclin B2 expression in invasive breast carcinoma is associated with unfavorable clinical outcome.
    Shubbar E; Kovács A; Hajizadeh S; Parris TZ; Nemes S; Gunnarsdóttir K; Einbeigi Z; Karlsson P; Helou K
    BMC Cancer; 2013 Jan; 13():1. PubMed ID: 23282137
    [TBL] [Abstract][Full Text] [Related]  

  • 14. NEDD4 expression is associated with breast cancer progression and is predictive of a poor prognosis.
    Wan L; Liu T; Hong Z; Pan Y; Sizemore ST; Zhang J; Ma Z
    Breast Cancer Res; 2019 Dec; 21(1):148. PubMed ID: 31856858
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prognostic significance of interferon regulating factor 4 (IRF4) in node-negative breast cancer.
    Heimes AS; Madjar K; Edlund K; Battista MJ; Almstedt K; Gebhard S; Foersch S; Rahnenführer J; Brenner W; Hasenburg A; Hengstler JG; Schmidt M
    J Cancer Res Clin Oncol; 2017 Jul; 143(7):1123-1131. PubMed ID: 28251349
    [TBL] [Abstract][Full Text] [Related]  

  • 16. BAG-1/SODD, HSP70, and HSP90 are potential prognostic markers of poor survival in node-negative breast carcinoma.
    Davidson B; Valborg Reinertsen K; Trinh D; Reed W; Bøhler PJ
    Hum Pathol; 2016 Aug; 54():64-73. PubMed ID: 27038683
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Gli1 is a potential cancer stem cell marker and predicts poor prognosis in ductal breast carcinoma.
    Ni W; Yang Z; Qi W; Cui C; Cui Y; Xuan Y
    Hum Pathol; 2017 Nov; 69():38-45. PubMed ID: 28965964
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Gene expression of PMP22 is an independent prognostic factor for disease-free and overall survival in breast cancer patients.
    Tong D; Heinze G; Pils D; Wolf A; Singer CF; Concin N; Hofstetter G; Schiebel I; Rudas M; Zeillinger R
    BMC Cancer; 2010 Dec; 10():682. PubMed ID: 21159173
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Outcomes in patients with early-stage breast cancer who underwent a 21-gene expression assay.
    Barcenas CH; Raghavendra A; Sinha AK; Syed MP; Hsu L; Patangan MG; Chavez-MacGregor M; Shen Y; Hortobagyi GH; Valero V; Giordano SH; Ueno NT; Tripathy D
    Cancer; 2017 Jul; 123(13):2422-2431. PubMed ID: 28199747
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Lectin histochemistry reveals SNA as a prognostic carbohydrate-dependent probe for invasive ductal carcinoma of the breast: a clinicopathological and immunohistochemical auxiliary tool.
    dos-Santos PB; Zanetti JS; Vieira-de-Mello GS; Rêgo MB; Ribeiro-Silva A A; Beltrão EI
    Int J Clin Exp Pathol; 2014; 7(5):2337-49. PubMed ID: 24966944
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.